Abstract
To enhance the clinical awareness and vigilance of healthcare professionals, such as therapists, cardiologists and neurologists, in the detection of ATTR amyloidosis among patients suffering from multi-organ damage, particularly in cases where heart failure with a preserved ejection fraction is progressing and resistant to standard treatment
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call